RICHMOND, VA, and PITTSBURGH, April 25, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Wako Chemicals U.S.A. Corporation (Fujifilm), a supplier of high purity chemicals and reagents, and Predictive Oncology Inc., (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that the companies have entered into a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products. Per the terms of the agreement, Predictive Oncology will utilize its novel EndoPrep™ sample treatment technology (EndoPrep), together with Fujifilm’s PYROSTAR™ bacterial endotoxin detection reagent (PYROSTAR), to detect residual endotoxins more accurately in biopharmaceuticals by eliminating protein interference from the drug product in the detection assay.
Fujifilm plots another $1.2B expansion, hiring spree at NC site
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
Fujifilm Corporation is spreading the wealth across two production units as the contract development and manufacturing organization (CDMO) juggernaut works through a cell therapy expansion.
LONDON, Nov 1 (Reuters) - Novo Nordisk NOVOb.CO has hired FUJIFILM Diosynth Biotechnologies to fill Wegovy injection pens, a source familiar with the matter told Reuters, as the Danish drugmaker scrambles to boost output of its hugely popular weight-loss drug.
LONDON, Nov 1 (Reuters) - The story quoting a source saying Novo Nordisk has hired a FUJIFILM unit to help make the Wegovy weight-loss drug is wrong and withdrawn. FUJIFILM denies it, and Reuters cannot confirm an agreement. No replacement story is planned.
FUJIFILM Cellular Dynamics, a global developer and manufacturer of human induced pluripotent stem cells (iPSC), launched its human iPSC-derived iCell Blood-Brain Barrier Isogenic Kit for neuroscience research and drug discovery for neuroactive drugs. The first-of-its-kind kit models the human blood-brain barrier and can advance drug discovery, drug development and medical research for central nervous system (CNS) disorders.
Fujifilm India, a pioneer in healthcare imaging and information systems has formalized their partnership with the department of pulmonary medicine, thoracic oncology disease management group, Tata Memorial Centre (TMC), Mumbai for establishing a training facility at TMC.
Manipal Hospitals has entered into an agreement with Fujifilm India to leverage the latter’s digital technology for storing sensitive medical documents and images.
Japanese behemoth Fujifilm Corporation has entered into an asset purchase agreement to acquire the global digital pathology business of Tampa, Florida-based Inspirata, Inc.